Cargando…

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade

BACKGROUND: CD8+ tissue-resident memory T (T(RM)) cells, marked by CD103 (ITGAE) expression, are thought to actively suppress cancer progression, leading to the hypothesis that their presence in tumors may predict response to immunotherapy. METHODS: Here, we test this by combining high-dimensional s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banchereau, Romain, Chitre, Avantika S., Scherl, Alexis, Wu, Thomas D., Patil, Namrata S., de Almeida, Patricia, Kadel, III, Edward E., Madireddi, Shravan, Au-Yeung, Amelia, Takahashi, Chikara, Chen, Ying-Jiun, Modrusan, Zora, McBride, Jacqueline, Nersesian, Rhea, El-Gabry, Ehab A., Robida, Mark D., Hung, Jeffrey C., Kowanetz, Marcin, Zou, Wei, McCleland, Mark, Caplazi, Patrick, Eshgi, Shadi Toghi, Koeppen, Hartmut, Hegde, Priti S., Mellman, Ira, Mathews, W. Rodney, Powles, Thomas, Mariathasan, Sanjeev, Grogan, Jane, O'Gorman, William E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Immunotherapy Biomarkers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032254/ https://www.ncbi.nlm.nih.gov/pubmed/33827905 http://dx.doi.org/10.1136/jitc-2020-002231

Ejemplares similares

SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer
por: Viotti, Manuel, et al.
Publicado: (2018)

CD8(+) T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy
por: Huseni, Mahrukh A., et al.
Publicado: (2023)

Molecular determinants of response to PD-L1 blockade across tumor types
por: Banchereau, Romain, et al.
Publicado: (2021)

SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
por: Madireddi, Shravan, et al.
Publicado: (2012)

Correction: SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
por: Madireddi, Shravan, et al.
Publicado: (2012)

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses
por: Banta, Karl L., et al.
Publicado: (2022)

Microenvironmental regulation of tumour immunity and response to immunotherapy
por: Kockx, Mark M, et al.
Publicado: (2021)

In silico tools for accurate HLA and KIR inference from clinical sequencing data empower immunogenetics on individual-patient and population scales
por: Chen, Jieming, et al.
Publicado: (2020)

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)
por: Powles, Thomas, et al.
Publicado: (2015)

Integration of human stem cell-derived in vitro systems and mouse preclinical models identifies complex pathophysiologic mechanisms in retinal dystrophy
por: Jones, Melissa K., et al.
Publicado: (2023)

Generation of Human B-Cell Lines Dependent on CD40-Ligation and Interleukin-4
por: Banchereau, Jacques
Publicado: (2015)

High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate
por: Ingle, Gladys S, et al.
Publicado: (2008)

Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry
por: Strickland, Faith M, et al.
Publicado: (2016)

TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
por: Chiang, Eugene Y, et al.
Publicado: (2022)

Helminth-induced CD19(+)CD23(hi) B cells modulate experimental allergic and autoimmune inflammation
por: Wilson, Mark S, et al.
Publicado: (2010)

P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009)

CD40 Ligation on Human Cord Blood CD34(+)Hematopoietic Progenitors Induces Their Proliferation and Differentiation into Functional Dendritic Cells
por: Flores-Romo, Leopoldo, et al.
Publicado: (1997)

Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
por: Fehlings, Michael, et al.
Publicado: (2019)

Expansion of Melanoma-specific Cytolytic CD8(+) T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34(+) Progenitor-derived Dendritic Cells
por: Paczesny, Sophie, et al.
Publicado: (2004)

MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction
por: Irving, Bryan A, et al.
Publicado: (2013)

Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells
por: Neidleman, Jason A., et al.
Publicado: (2017)

Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
por: Vanje, Manjushri Madhukar, et al.
Publicado: (2019)

Single Cell Analysis of Blood Mononuclear Cells Stimulated Through Either LPS or Anti-CD3 and Anti-CD28
por: Lawlor, Nathan, et al.
Publicado: (2021)

Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas
por: Fedorowicz, Grazyna, et al.
Publicado: (2009)

Mass Cytometry Defines Virus-Specific CD4(+) T Cells in Influenza Vaccination
por: Subrahmanyam, Priyanka B., et al.
Publicado: (2020)

Dendritic Cells Enhance Growth and Differentiation of CD40-activated B Lymphocytes
por: Dubois, Bertrand, et al.
Publicado: (1997)

Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4(+) T Cells
por: Grosjean, Isabelle, et al.
Publicado: (1997)

The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand
por: Grouard, Géraldine, et al.
Publicado: (1997)

Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors
por: Castiglioni, Alessandra, et al.
Publicado: (2023)

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
por: Kowanetz, Marcin, et al.
Publicado: (2018)

P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
por: Kowanetz, M, et al.
Publicado: (2014)

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subsets and outcome in colorectal cancer
por: Ziai, James, et al.
Publicado: (2014)

Single-cell analysis reveals clonally expanded tumor-associated CD57(+) CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade
por: Fehlings, Michael, et al.
Publicado: (2022)

Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab
por: Vennapusa, Bharathi, et al.
Publicado: (2019)

High cell-surface density of HER2 deforms cell membranes
por: Chung, Inhee, et al.
Publicado: (2016)

Requirements for CD1d Recognition by Human Invariant Vα24(+) CD4(−)CD8(−) T Cells
por: Exley, Mark, et al.
Publicado: (1997)

TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
por: Mariathasan, Sanjeev, et al.
Publicado: (2018)

IRF4-dependent dendritic cells regulate CD8(+) T cell differentiation and memory responses in influenza infection
por: Ainsua-Enrich, Erola, et al.
Publicado: (2019)

Genome-Wide Identification of Alternatively Spliced mRNA Targets of Specific RNA-Binding Proteins
por: Robida, Mark D., et al.
Publicado: (2007)

In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53
por: Deneka, Magdalena, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_a2gbgnlmekh4kmqc4intkfmrpt